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Introduction  
Adenoid cystic carcinoma is known commonly as 
a tumor of salivary glands. However, it also may 
be seen rarely in lacrimal glands, mucosal glands 
of the upper respiratory tract, external auditory 
canal, breast, Bartholin’s glands of the vulva, 
uterine cervix, prostate gland, esophagus, and 
other sites. It may also involve the skin by direct 
or perineural invasion or as a site of distant 
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Abstract  
Introduction: Primary cutaneous adenoid cystic carcinoma (PACC) is a rare slow-growing tumor.  
Presentation of the case: We report a 62 year-old woman presented with a nodular lesion on the scalp who had three 
operations before for recurring lesion at the same localization. In the operation, we detected a lesion which was adherent 
to the subcutaneous tissue. The lesion was firm and gray-white colored, and invading the surrounding soft tissues. 
According to histopathological findings, the patient diagnosed with adenoid cystic carcinoma.   
Conclusions: Primary cutaneous adenoid cystic carcinoma is a rare tumor that the etiology, origin, and treatment are still 
controversial. The metastases must be ruled out from other sites, especially from the salivary glands after the its 
pathological diagnosis.    
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metastases [1]. Primary cutaneous adenoid cystic 
carcinoma (PACC) is a rare slow-growing tumor 
and firstly described by Boggio in 1975 [2]. There 
are about 60 cases in the literature. The most 
common site of PCACC is the scalp. The other 
sites are chest, abdomen, back, axilla, eyelid, and 
perineum. It may be asymptomatic or may present 
with local hair loss, tenderness, pruritus, or pain. 
It may recur locally and time interval for 
recurrence ranges between one month and 35 
years [1].  
    Herein, we are presenting a new case with 
PCACC of the scalp that had three operations 
before for recurring lesion at the same localisation 
with no pathological diagnosis. 
Case Presentation 
A 62 year-old woman presented with a nodular 
lesion on the scalp. It was itching and mildly 
painful. Her medical history revealed that she was 
operated three times before for this lesion in the 
last 2 years. The last operation was about 6 
months ago, but there was no histopathological 
diagnosis. There was no history of weight loss. In 
the physical examination, a firm nodular lesion 
was detected on the right parietal region. It was 
not mobile and was very close to the traces of the 
previous sutures. Neurological examination was 
completely intact. Brain computed tomography 
was performed that did not reveal any intracranial 
extension of the lesion or any other accompanying 
lesions. Our clinical approach revealed two 
suggestions about the nature of the lesion. First, as 
the lesion was recurring and had no prior 
diagnosis, it might be any type of tumor. Second, 
there might be a foreign body reaction due to the 
previous operations. At the operation, we 
determined that there was no foreign body. We 
detected a lesion which was adherent to the 
subcutaneous tissue. The lesion was firm and 
gray-white colored, and showed invasion to the 
surrounding soft tissues. It was excised broadly. 
Grossly the biopsy was composed of skin and 
subcutaneous tissue that was measured as 
3.2x2.3x0.8 cm. Macroscopic examination 
revealed a gray-white colored lesion about 1 cm 
with irregular borders. Microscopically, the lesion 
was localised in the dermis and subcutaneous 
tissue without an epidermal connection. The 
lesion was composed of myoepithelial and 
basaloid cells forming cystically dilated 
cribriform and tubular patterns, and focally solid 
areas (Figure 1). Some true lumina were seen. 
There were basal membrane like material, positive 
with PAS histochemically, among the tumor cells. 
Histochemically, mucin was detected in the cystic 
spaces and between the tumor cells with Alcian 
blue (pH: 2.5) (Figure 2). Immunohistochemical 
analysis revealed strong positivity with EMA, and 
weak positivity with CEA in true luminal cells. 
SMA, p63 and S100 immunostained 
myoepithelial cells. CD117, chromogranin A and 
synaptophysin were negative. Twenty two mitotic 
figures were detected in ten high power 
microscopic fields, and Ki-67 proliferation index 
was about 40-50%. The lesion was entirely 
examined but no perineural invasion or 
angiolymphatic invasion was detected. 
Coagulation necrosis was present focally in the 
lesion. Surgical margins were tumor free. The 
tumor was diagnosed as adenoid cystic carcinoma.  
After the histopathological diagnosis, tumor 
markers were examined and found to be negative. 
Neck, thorax, upper and lower abdominal 
computed tomography images were performed, 
and no other lesion was detected. The metastatic 
tumor was ruled out by these additional 
examinations and we diagnosed the case as 
primary cutaneous adenoid cystic carcinoma of 
the scalp. The patient was advised to receive 
chemotherapy or radiotherapy because of the high 
recurrence risk, but she did not accept any 
therapies. She is still under clinical follow-up 
without recurrence for 8 months.  
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Figure 1 Dermal tumor showing cribriform, tubular and solid patterns (H&E, x40). Inset, infiltrating 
component of the tumor (H&E, x100). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Mucinous secretion in some ducts and between the tumor cells histochemically (Alcian blue  pH 
2.5, x200). 
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Figure 3 An intraoperative appearance of the tumor 
 
Discussion                  
For the diagnosis of PCACC, it is crutial to rule 
out metastasis because adenoid cystic carcinoma 
can occur at other sites mostly in salivary glands, 
palate, submaxillary glands, and rarely in 
nasopharynx, external auditory canal, breast, 
prostate gland, uterine cervix or lung etc [3].  
PCACC is a slow-growing nodular malignancy 
and has an indolent course with local recurrences 
and rarely metastasis. The most common site of 
PCACC is the scalp and 41% of PCACC arises on 
it. PCACC shows a mild female predominance 
between 60-70 years [3,4,5,6].  The patients with 
PCACC are usually asymptomatic. However, 
local hair loss, tenderness, pain, and/or pruritus 
may occur [1]. Our patient had complaints of 
itching and mild local pain. 
Although PCACC is known for more than 35 
years, the origin and etiology are still uncertain [3]. 
There are some reports in the literature suggesting 
that the tumor may originate from eccrine glands, 
apocrine glands or modified apocrine glands.  
Histopathologically, the PCACC is a poorly 
circumscribed tumor consisting of myoepithelial 
and basaloid cells with cribriform, tubular, and 
solid formations in a loose fibrous stroma with 
mucinous component [3]. The PCACC is reported 
to show immunoreactivity with pan-cytokeratin, 
EMA, CEA, CD117, keratin 7 in the basaloid cells, 
and show immunoreactivity with calponin, p63, 
CD10, SMA and S100 in the myoepithelial 
component in the literature. Also, PCACC shows 
weaker positivity with CEA than the 
extracutaneous adenoid cystic carcinomas, similar 
to our case [4]. Histopathological and 
immunohistochemical findings of the present case 
were consistent with the cases reported in the 
literature. Adenoid basal cell carcinoma, 
cribriform carcinoma, apocrine mixed tumor of 
the skin, mucinous apocrine carcinoma, 
cylindroma, and neuroendocrine carcinomas are 
the tumors that should be ruled out in the 
histological differential diagnosis [4].  
The standard management of PCACC is the 
surgical excision [4]. Wide local excision with 
tumor-free margins is the established treatment of 
choice. Also, Mohs surgery is well defined in the 
literature with seven cases [7]. In rare instances, 
use of chemotherapy and radiotherapy has been 
reported [4,8].   
PCACC tends to recur frequently after surgical 
excision. It is suggested that the main mechanism 
in the development of recurrence is perineural 
invasion that is seen in 76% of the PCACC. It is 
reported that the cases with perineural invasion 
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have recurrence rate about 46%, however the 
cases without perineural invasion show recurrence 
rate about 22% [4]. No perineural invasion was 
detected in the present case but high recurrence 
rate suggests that the prior excisions might 
probably show perineural invasion. Recurrence 
time of the PCACC may vary between one month 
and 35 years [4,5,6]. Our patient was operated for 
three times in the last 2 years before the present 
excision. The last operation was about 6 months 
ago. We performed a wide excision.  
Conclusion 
The PCACC is a rare tumor that the etiology, 
origin, and treatment are still controversial. The 
metastases must be ruled out from other sites, 
especially from the salivary glands after the its 
pathological diagnosis.  
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